Recruiting Representative Trial Populations Takes More Than Intent

Trial populations that don't reflect the patients who will use a treatment produce weaker evidence — and increasingly, they produce regulatory findings. FDA guidance now pushes sponsors toward formal diversity action plans, and sponsors pass that pressure to sites. Good intentions aren't a plan. Operations are.

Where underrepresentation actually happens

It's rarely one dramatic barrier; it's stacked small ones:

• Recruitment materials only in English, at a college reading level
• Screening visits offered only during working hours
• Sites located far from the communities being recruited
• Outreach channels that never reach the target population
• Histories of research mistrust that a flyer can't overcome

Operational moves that work

Meet people where they are. Partnerships with community clinics, churches, barbershops, and patient advocacy groups outperform ads for underrepresented groups — because the message arrives through someone already trusted.

Remove logistical friction. Evening and weekend visit slots, transportation stipends, and dependent-care support address the reasons eligible people decline. Many "recruitment" problems are actually retention-of-interest problems.

Translate properly. Materials, consent conversations, and pre-screeners in the community's language — reviewed by native speakers, not just machine-translated.

Track it. You can't manage representation you don't measure. Enrollment demographics by source, reviewed monthly, show which channels are and aren't reaching the intended population while there's still time to adjust.

The long game

Sites that invest in community presence between studies — showing up when they're not asking for anything — build the trust that makes representative enrollment achievable when the study opens. That reputation compounds. It's also increasingly a competitive differentiator when sponsors select sites: demonstrated access to diverse populations is now a line item in feasibility questionnaires.